首页 | 本学科首页   官方微博 | 高级检索  
     


Treatment outcomes and validation of the stopping rule for response to peginterferon in chronic hepatitis B: A Thai nationwide cohort study
Authors:Phunchai Charatcharoenwitthaya  Wattana Sukeepaisarnjaroen  Teerha Piratvisuth  Satawat Thongsawat  Theeranun Sanpajit  Soonthorn Chonprasertsuk  Woramon Jeamsripong  Ekawee Sripariwuth  Piyawat Komolmit  Tanisa Patcharatrakul  Rattana Boonsirichan  Chalermrat Bunchorntavakul  Supoj Tuntipanichteerakul  Tawesak Tanwandee  for the Thai Association for the Study of the Liver on Chronic Hepatitis B
Affiliation:1. Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand;2. Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand;3. Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand;4. Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand;5. Phramongkutklao Hospital, Bangkok, Thailand;6. Faculty of Medicine, Thammasat University, Pathum Thani, Thailand;7. Buddhachinaraj Hospital, Phitsanulok, Thailand;8. Faculty of Medicine, Naresuan University, Phitsanulok, Thailand;9. Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand;10. Police General Hospital, Bangkok, Thailand;11. BMA Medical College and Vajira Hospital, Bangkok, Thailand;12. Rajavithi Hospital, Bangkok, Thailand;13. Bhumibol Adulyadej Hospital, Bangkok, Thailand
Abstract:
Keywords:antiviral therapy  chronic hepatitis B  peginterferon  quantitative HBsAg  stopping rule
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号